Earnings Winners & Losers: ISHG Beats Forecasts; JNJ Ortho Sales Still Soft; ABT; DNH
Executive Summary
Earnings season kicked off last week with Johnson & Johnson, Abbott, Danaher and Intuitive Surgical being among the first wave of second-quarter and first-half results to be released. Abbott, J&J and Danaher experienced steady growth, but robotic surgery leader Intuitive announced some particularly nice numbers, beating analyst expectations.
You may also be interested in...
Q3 Earnings Spotlight: Abiomed Shines Among Cardiology Device-Makers
Reported sales and earnings from the publicly traded cardiovascular device companies show strong performance across the sector, spurred by new approvals and clinical trials, in the quarter that ended Sept. 30. Here's a recap of results from the cardio device companies that have reported so far, including Abbott, Abiomed, and Reva.
Ortho Roundup: Strong Knees Let SYK Stands Tall Against Recon Rivals ZMH, SNN And JNJ
The top four orthopedic implant makers have released their second-quarter and half-year results. Following DePuy Synthes report of a still-soft but recovering reconstructive implant market, this edition of Earnings Winners And Losers look at how the other three big recon players – Zimmer Biomet, Stryker, and Smith & Nephew fare. It also offers a peek into the top- and bottom-line results of the other key names within Medtech Insight's Top 10 orthopedic companies.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.